Arbutus Biopharma Corporation Cash Conversion Cycle 2011-2026 | ABUS

Annual Cash Conversion Cycle Arbutus Biopharma Corporation

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.5	10.5	36.7	46.2	57.9	91.6	18.1	151	1.78	42.4	-12	72.8	30.6

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
151	-12	44.5

Quarterly Cash Conversion Cycle Arbutus Biopharma Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
166	9.38	92.9	-	115	103	117	-	46.9	51.8	27.4	-	14.1	4.21	8.02	-	40.5	50.2	55.6	-	78.6	79.1	77	67.9	35.9	168	177	53.5	53.5	74.9	35.6	14.5	5.32	35.3	131	-128	32.2	80.6	96.9	7.25	22.6	26.7	28.4	39.9	39.8	95.9	20.8	14.2	3.6	3.75	25.5	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
177	-128	52.2

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	-400	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	123	$ 33.23	-4.03 %	$ 584 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	115	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	173	$ 3.72	-2.75 %	$ 1.11 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	-123	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	-256	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	-114	$ 64.66	-1.37 %	$ 12.4 B	USA
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	85.5	-	-	$ 789 M	USA
Certara CERT	81.8	$ 7.16	1.49 %	$ 1.15 B	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Catalyst Pharmaceuticals CPRX	120	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Codexis CDXS	-48.2	$ 0.99	-3.28 %	$ 72.7 M	USA
CTI BioPharma Corp. CTIC	-216	-	-	$ 1.2 B	USA
Cyclacel Pharmaceuticals CYCC	-1.6 K	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	-1.6 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	-101	-	-	$ 2.18 B	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Denali Therapeutics DNLI	1.89	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Eton Pharmaceuticals ETON	-6.66	$ 17.54	-3.36 %	$ 450 M	USA
Evofem Biosciences EVFM	-630	-	7.55 %	$ 38.1 M	USA